BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2016
View Archived Issues
Concomitant pan-Raf/PI3K inhibition as promising new therapeutic strategy in multiple myeloma
Read More
Hsa-miR-623 suppresses lung adenocarcinoma cell proliferation and invasion
Read More
miR-558 and Smad4 as novel therapeutic targets for gastric cancer
Read More
Ang-Tie-2 interventions as potential adjunctive therapeutics for severe malaria
Read More
Sumitomo Dainippon Pharma develops PDE1 inhibitors
Read More
Wuhan LL Science and Technology Development announces nitric oxid donors
Read More
Sarepta licenses European rights to Summit's utrophin modulator pipeline for DMD
Read More
Gene therapy as a promising new approach for treating cystic fibrosis lung disease
Read More
Tenax Therapeutics provides clinical update for levosimendan
Read More
Achilles Therapeutics launched to develop immunotherapies for cancer
Read More
Redhill Biopharma commences phase II study of Yeliva in HCC
Read More
Insmed and AstraZeneca enter worldwide license agreement
Read More
Triphase Accelerator obtains rights to ADC from Catalent Biologics
Read More
Mitsubishi Tanabe and Daiichi Sankyo announce progress in malaria research programs with MMV
Read More
Gilead initiates phase II trial of GS-9876 in patients with active rheumatoid arthritis
Read More
MD Anderson initiates first-in-human study of IACS-010759 in relapsed or refractory AML
Read More
New company Kymo Therapeutics formed to advance KMO inhibitors
Read More
DTX-401 named FDA orphan drug for treating glycogen storage disease type Ia
Read More
Scynexis reports full results from phase II studies of antifungal SCY-078
Read More
Alnylam Pharmaceuticals discontinues development of revusiran
Read More
Cepheid launching Xpert Bladder Cancer Monitor in Europe
Read More
Immunomic Therapeutics and Nature Technology Corporation announce new license agreement
Read More
FDA warns on risk of HBV reactivation in patients taking direct-acting antivirals for HCV
Read More
Helmholtz-Zentrum fur Infektionsforschung develops lecB inhibitors
Read More
Toray Industries prepares and tests agents for urinary incontinence
Read More
Almirall patents Nav1.7 channel blockers for pain
Read More
Novira Therapeutics describes agents for HBV infection
Read More
Exosome Diagnostics and Amgen partner on liquid biopsy diagnostics
Read More